TP53 and colorectal cancer: Previous studies have shown that the AKT-MDM2-p53 signaling pathway significantly affects cell apoptosis and is associated with the development and progression of various cancers, including colorectal cancer.42 Thus, targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis both in vitro and in vivo.